Antidepressant mechanism of ketamine: perspective from preclinical studies
about
Practical application of the neuroregenerative properties of ketamine: real world treatment experienceModeling mania in preclinical settings: A comprehensive review.The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviorsA Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate Cortex.Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress.Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder.Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition.Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse.Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder.Multi-Watt Near-Infrared Phototherapy for the Treatment of Comorbid Depression: An Open-Label Single-Arm Study.Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3.Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.
P2860
Q26748766-801DEFBC-E049-4B84-A86A-4397066657C4Q30359575-ABD27C19-7079-4838-8BC1-4CA5544302B0Q37307156-F8C4700F-F21F-4190-A53C-E07A5A87E0F0Q38434930-02CE5E91-5592-49D0-A84F-482A9177DEB8Q38793772-EADFDA0D-4486-401D-B7C1-93ADF08DEF1BQ38818235-DF80DBA5-4005-4FD2-B40C-1DF953650D34Q39189451-B0D5B380-B2A2-432A-819A-A7E34E5666EFQ39295832-3876A1AC-B067-46B1-91D4-D675F7B53FE9Q41687504-B6C6052B-F88C-4629-8ACC-15318F61D6B9Q42034477-8109F869-7C1F-4024-AEED-A22F37AB3ABDQ42369081-995397ED-0AE2-4227-AF36-C4428984D47BQ42369985-95CE086C-D514-4645-8A11-0BA143B42B8BQ47300330-865BCC02-9042-4AEA-9960-2DCC2DC96593Q47306135-64FC0BD8-0B3D-4199-AEE5-F1090651B68FQ48039552-7C39A522-E1F6-4BD7-A667-35F19D2DDBD9Q52604451-AEF84C98-5295-4D0E-B52C-F5EFCC2C9066Q55535831-CE9AD9D2-49CC-484C-99D3-7E4D742D9F13
P2860
Antidepressant mechanism of ketamine: perspective from preclinical studies
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Antidepressant mechanism of ketamine: perspective from preclinical studies
@ast
Antidepressant mechanism of ketamine: perspective from preclinical studies
@en
Antidepressant mechanism of ketamine: perspective from preclinical studies
@nl
type
label
Antidepressant mechanism of ketamine: perspective from preclinical studies
@ast
Antidepressant mechanism of ketamine: perspective from preclinical studies
@en
Antidepressant mechanism of ketamine: perspective from preclinical studies
@nl
prefLabel
Antidepressant mechanism of ketamine: perspective from preclinical studies
@ast
Antidepressant mechanism of ketamine: perspective from preclinical studies
@en
Antidepressant mechanism of ketamine: perspective from preclinical studies
@nl
P2093
P2860
P3181
P356
P1476
Antidepressant mechanism of ketamine: perspective from preclinical studies
@en
P2093
Chi-Tso Chiu
De-Maw Chuang
Hsiao-Mei Liao
Lisa Scheuing
P2860
P3181
P356
10.3389/FNINS.2015.00249
P407
P577
2015-01-01T00:00:00Z